2022 Speakers

Browse our confirmed speakers below, or click here to take a look at the 2022 Agenda

Speakers

Alan Griffith

Vice President of Research • PureSpring Therapeutics
Speakers

Alexander Natz

 • EUCOPE
Speakers

Alexandre Reeber

CEO • Core Biogenesis
Speakers

Amandine Breton

Associate Director MSAT, Cell & Gene Therapies • Orchard Therapeutics
Speakers

Amro Eid

Senior Policy Analyst Lifesciences • Freemind Group
Speakers

Angela Justice

Chief People Officer • TCR2 Therapeutics
Speakers

Ann-Hunter Van Kirk

Senior Analyst Cell & Gene Therapy • Bloomberg Intelligence
Speakers

Anna Dickinson

Senior Policy Analyst Lifesciences • Public Policy Projects
Speakers

Anthony Davies

Founder & Ceo • Dark Horse Consulting
Speakers

Arthur Stril

Chief Business Officer • Cellectis
Speakers

Bryan Kobel

CEO • TC Biopharm
Speakers

Bryan Poltilove

Operating Partner • BroadOak Partners
Speakers

Chaminda Salgado

Vice President of CMC • T-cypher Bio
Speakers

Daniel Cermeno

Product Manager • Core Biogenesis
Speakers

Daniel Marroyen

Senior Life Science Industry Consultant, Europe • Emerson Automation Solutions
Speakers

David Allison

Chief Executive • TREAT-NMD
Speakers

David Sourdive

Executive Vice President Strategic Initiatives • Cellectis
Speakers

David Wolton

Engineering Technology Lead • Takeda
Speakers

Dmitrij Hristodorov

Partner • Forbion
Speakers

Dragan Djordjevic

Director, Machine Learning & Digital CMC Cell Therapy Cell Therapy Development & Automation • Takeda
Speakers

Edward Samuel

EVP Technical Operations • Achilles Therapeutics
Speakers

Elsa Abranches

Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • Astra Zeneca
Speakers

Emmanuelle Cameau

Strategic Technology Partnership Leader • Pall Corporation
Speakers

Fabio Fachin

Head Cell Therapy Process Development & Automation & Digital Technologies • Takeda
Speakers

Frank Thielmann

Chief Executive Officer • Takeda
Speakers

Giovanni Lorenzon

Bioprocess Specialist • Eppendorf
Speakers

Hanna Lesch

CTO • Exothera SA
Speakers

Jacqueline Barry

Chief Clinical Officer • Cell and Gene Therapy Catapult
Speakers

Jenny Prange

Head of GMP Production, CSO and Co-Founder • Muvon Therapeutics
Speakers

Jens Hasskarl

Chief Medical Officer • Tigen Pharma
Speakers

Joel Eichmann

Co-Founder • Green Elephant Biotech
Speakers

John Campbell

Director, Tissues Cells & Advanced Therapeutics • Scottish National Blood Transfusion Service
Speakers

Jose Angel Aibar

President • NHS Blood and Transport
Speakers

Julia Sable

Director CMC Project Management • Tmunity Therapeutics
Speakers

Karin Blumer

Director Global Patient Engagement • Novartis
Speakers

Khushboo Sharma

Chief of Staff and Senior Vice President • Biotechnology Innovation Organization
Speakers

Kinnari Patel

President & COO • Rocket Pharma
Speakers

Lisa Deschamps

Chief Executive Officer • Adva Biotechnology
Speakers

Ludwig Camusot

Chief Corporate Development Officer • Cell Matters
Speakers

Magali Taiel

 • GenSight Biologics
Speakers

Mark Kotter

Founder • Bit Bio
Speakers

Mark Lowdell

CSO/CMO • INmune Bio
Speakers

Mark Throsby

COO/CSO • Gadeta
Speakers

Mark Trusheim

Strategic Director, NEWDIGS and Visiting Scientist, • Massachusetts Institute of Technology (MIT)
Speakers

Martin Murphy

Chief Executive Officer • Syncona Investment
Speakers

Michael Leek

Chief Executive • TC Biopharm
Speakers

Michela Gabaldo

Head Alliance Management & Regulatory Affairs • Fondazione Telethon
Speakers

Miguel Forte

CEO • Bone Therapeutics
Speakers

Mustafa Munye

Director R&D Operations • Complement Therapeutics
Speakers

Namir Hassan

CEO • Zelluna
Speakers

Natalie Ward

Associate Director, Regulatory Affairs, CMC • Adaptimmune
Speakers

Neil Dugdale

UK Country Lead • GenSight Biologics
Speakers

Nicholas Medcalf

Deputy Challenge Director for the Medicines Manufacturing Challenge • Innovate UK
Speakers

Nicola Redfern

Former Vice President Northern Europe • Bluebird Bio
Speakers

Oliver Sexton

Investment Director • UK Innovation & Science Seed Fund
Speakers

Owen Smith

Partner • 4Bio
Speakers

Pamela Tranter

Head Translational Research Group, UCL Translational Research Office • UCL
Speakers

Pascal Joly

Principal • Catenion
Speakers

Qasim Rafiq

Associate Professor Cell & Gene Therapy • UCL
Speakers

Rafiq Hasan

CEO • Complement Therapeutics
Speakers

Rodolphe Clerval

CEO • Coave Therapeutics
Speakers

Ryan Hicks

Senior Director – Head of Bioscience Cell Therapy, BioPharmaceuticals, R&D Cell Therpay • Astra Zeneca
Speakers

Sanjin Zvonic

Vice President Business Development • Dark Horse Consulting
Speakers

Shree Patel

EVP Patient Supply Operations • Achilles Therapeutics
Speakers

Simon Chandler

CEO • Rinri Therapeutics
Speakers

Sofia Hakansson Buch

Vice President for Cell Therapy CMC • Novo Nordisk
Speakers

Stefan Hendricks

Senior Vice President Global Head Cell & Gene Therapy • Novartis
Speakers

Stefanos Theoharis

Chief Business Officer • Bone Therapeutics
Speakers

Stephan Grupp

Medical Director Cell & Gene Therapy Lab • Children’s Hospital of Philadelphia
Speakers

Stephen Sullivan

Programme Manager & International Liason Officer • GAiT
Speakers

Steve Bloodworth

Head of Commercial Partnering & MarTech Deployment, • Astra Zeneca
Speakers

Stuart Curbishley

Head of Business and Project Development – Advanced Therapies • University of Birmingham
Speakers

Sven Kili

Chief Executive Officer • Antion
Speakers

Takis Athanasopoulos

Director, Head of Patient Operations, Product Development & Supply Cell & Gene Therapy • GSK
Speakers

Tim Funnell

Partner • Monograph Capital
Speakers

Tom Whitehead

Co Founder & President • Emily Whitehead Foundation
Speakers

Troels Jordansen

CEO • GlycoStem
Speakers

Uta Griesenbach

Professor of Molecular Medicine, National Heart and Lung Institute • Imperial College London